Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Baker Hughes A | BKR | 1. avr 2025 | 44.80 | +1.93 |
Ball | BALL | 1. avr 2025 | 52.40 | +0.63 |
Bank Of America | BAC | 1. avr 2025 | 41.49 | -0.58 |
Bank Of New York Mellon | BK | 1. avr 2025 | 83.77 | -0.12 |
Baxter International | BAX | 1. avr 2025 | 34.02 | -0.61 |
Becton, Dickinson And Co | BDX | 1. avr 2025 | 226.04 | -1.32 |
Berkshire Hathaway B | BRK-B | 1. avr 2025 | 532.99 | +0.08 |
Best Buy | BBY | 1. avr 2025 | 74.37 | +1.03 |
Bio-Techne | TECH | 1. avr 2025 | 57.35 | -2.18 |
Biogen | BIIB | 1. avr 2025 | 132.03 | -3.52 |
BlackRock | BLK | 1. avr 2025 | 944.08 | -0.25 |
Blackstone | BX | 1. avr 2025 | 142.80 | +2.16 |
Boeing | BA | 1. avr 2025 | 168.17 | -1.40 |
Booking | BKNG | 1. avr 2025 | 4 685.75 | +1.71 |
BorgWarner | BWA | 1. avr 2025 | 28.54 | -0.38 |
Boston Properties | BXP | 1. avr 2025 | 66.96 | -0.34 |
Boston Scientific | BSX | 1. avr 2025 | 101.24 | +0.36 |
Bristol-Myers Squibb | BMY | 1. avr 2025 | 59.55 | -2.36 |
Broadcom | AVGO | 1. avr 2025 | 168.52 | +0.65 |
Broadridge Financial Solutions | BR | 1. avr 2025 | 244.72 | +0.93 |
Brown & Brown | BRO | 1. avr 2025 | 124.11 | -0.23 |
Brown Forman B | BF-B | 1. avr 2025 | 33.50 | -1.30 |
Builders Firstsource | BLDR | 1. avr 2025 | 125.61 | +0.54 |
Bunge | BG | 1. avr 2025 | 77.85 | +1.87 |
C.H. Robinson Worldwide | CHRW | 1. avr 2025 | 102.76 | +0.35 |
Cadence Design Systems | CDNS | 1. avr 2025 | 258.79 | +1.75 |
Caesars Entertainment | CZR | 1. avr 2025 | 24.83 | -0.68 |
Camden Property Trust | CPT | 1. avr 2025 | 121.92 | -0.31 |
Campbell Soup | CPB | 1. avr 2025 | 39.90 | -0.05 |
Capital One Financial | COF | 1. avr 2025 | 178.22 | -0.60 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.